NIGMS Funding Opportunities
NIGMS Feedback Loop Blog
The goal of NIGMS funding policies is to maximize the scientific impact of investments in investigator-initiated biomedical research to drive fundamental scientific discoveries that advance understanding of human health and disease. To address this goal, the Institute strives to support a broad portfolio of research grants of high scientific and technical merit, as determined by peer review, in its mission areas.
However, in deciding to fund any application, NIGMS staff also considers other factors, including (consistent with applicable law):
It is important to understand that even applications with outstanding scores might not be funded if the investigator already has substantial other support.
Because NIGMS prioritizes funding for meritorious investigators who otherwise would not have support over providing additional grants to already well-funded investigators, the Institute is unlikely to award more than one NIGMS R01 to a PI (including multi-PI R01s).
In accordance with our Strategic Plan [PDF], NIGMS generally prioritizes funding the MIRA program over R01 awards.
In calculating budgets for grants, NIGMS staff considers each budget carefully and takes into account the science being conducted, the other support for the PI’s lab, the Institute’s budget, and other factors. PIs should not assume that they will be awarded the amount recommended by the study section. To fund as broad a portfolio of meritorious investigators as soon as possible and to improve overall returns on investments, NIGMS pays close attention to budget levels and gives large budget increases only in highly compelling cases.
Applicants are encouraged to contact NIGMS program staff with questions.
Specific policies related to funding are listed below: NIGMS Funding for Investigators with Substantial Research SupportNIGMS Interim Support PolicyResearch Grant Duration PolicySupport for Scientific Meetings